EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Benzylhydroxamic Acids as IRAP Inhibitors: Sulfonamide Variations

Mats Larhed, Johan Gising, Julia Beveridge, Marcus Söderström, Lorenzo Jacopo Ilic Balestri, Rubén Prieto-Díaz, Hugo Gutierrez-de-Teran, Luke R Odell, Mathias Hallberg

Synlett · 01.10.2025 · 36 (16) · 2666-2670

DOI: 10.1055/a-2562-7204 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Synlett, erschienen am 01.10.2025. Verfasst von Mats Larhed und 8 weiteren Autor:innen. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Vetenskapsrådet, Kjell och Märta Beijers Stiftelse.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Small-molecule inhibitors of the zinc metalloprotease insulin-regulated aminopeptidase (IRAP, EC 3.4.11.3), are a promising new class of potential cognitive enhancers for the treatment of neurodegenerative disorders such as Alzheimer’s disease. Previous studies identified a series of sulfonamide-substituted benzylhydroxamic acids with fair BBB permeability, no indication of efflux and subnanomolar potency. We herein report our further structural optimization of this compound series focusing on various alterations to the sulfonamide group. Notably, introduction of dihydropyridopyrimidine provided the most active small-molecule inhibitor compound reported to date, with an IC50 value of 34 nM. Molecular modeling studies, based on free energy perturbation simulations, show that the accommodation of the explored substituents on the binding mode proposed explain the experimental SAR herein reported and provide a rationale for the enhanced affinity of the optimized compounds.

Förderung

  • Vetenskapsrådet
  • Kjell och Märta Beijers Stiftelse

Zitieren

APA

Larhed, M., Gising, J., Beveridge, J., Söderström, M., Balestri, L. J. I., Prieto-Díaz, R., Gutierrez-de-Teran, H., Odell, L. R., & Hallberg, M. (2025). Benzylhydroxamic Acids as IRAP Inhibitors: Sulfonamide Variations. Synlett, 36(16), 2666-2670. https://doi.org/10.1055/a-2562-7204

Vancouver

Larhed M, Gising J, Beveridge J, Söderström M, Balestri LJI, Prieto-Díaz R, et al. Benzylhydroxamic Acids as IRAP Inhibitors: Sulfonamide Variations. Synlett. 2025;36(16):2666-2670. doi:10.1055/a-2562-7204

BibTeX
@article{Larhed2025,
  author = {Larhed, Mats and Gising, Johan and Beveridge, Julia and Söderström, Marcus and Balestri, Lorenzo Jacopo Ilic and Prieto-Díaz, Rubén and Gutierrez-de-Teran, Hugo and Odell, Luke R and Hallberg, Mathias},
  title = {Benzylhydroxamic Acids as IRAP Inhibitors: Sulfonamide Variations},
  journal = {Synlett},
  year = {2025},
  volume = {36},
  number = {16},
  pages = {2666--2670},
  doi = {10.1055/a-2562-7204}
}
Kostenlos starten →